176 related articles for article (PubMed ID: 18792427)
21. Japanese firms broaden investment focus to early biotech.
Louët S; Sipp D
Nat Biotechnol; 2004 Aug; 22(8):931-2. PubMed ID: 15286631
[No Abstract] [Full Text] [Related]
22. Europe's biotech renaissance.
Senior M
Nat Biotechnol; 2020 Apr; 38(4):408-415. PubMed ID: 32265563
[No Abstract] [Full Text] [Related]
23. Bonsai biotech.
Bains W
Nat Biotechnol; 2009 Mar; 27(3):233. PubMed ID: 19270667
[No Abstract] [Full Text] [Related]
24. Little biotech on the prairie.
Wolfson W
Chem Biol; 2007 Sep; 14(9):969-71. PubMed ID: 17884626
[No Abstract] [Full Text] [Related]
25. Europe discovers bioentrepreneurship.
Haycock P
Nat Biotechnol; 1998 May; 16 Suppl():6. PubMed ID: 9591249
[No Abstract] [Full Text] [Related]
26. Perspective: Biotech funding trends: Insights from entrepreneurs and investors.
Gruber AC
Biotechnol J; 2009 Aug; 4(8):1102-5. PubMed ID: 19685460
[TBL] [Abstract][Full Text] [Related]
27. Biotech firms jump on SARS bandwagon.
Basu P
Nat Biotechnol; 2003 Jul; 21(7):720. PubMed ID: 12833076
[No Abstract] [Full Text] [Related]
28. Biotechnology in Ireland: hard work, money and the brain gain.
O'Neill MF
Drug Discov Today; 2007 Feb; 12(3-4):108-11. PubMed ID: 17275730
[No Abstract] [Full Text] [Related]
29. Bioentrepreneurship 2002: at home in your lab.
Eisenhardt PE
Anal Bioanal Chem; 2002 Jan; 372(1):9-11. PubMed ID: 11939216
[No Abstract] [Full Text] [Related]
30. Biotech business Down Under.
Beckley C
Nature; 2004 Jun; 429(6991 Suppl):5-9. PubMed ID: 15175704
[No Abstract] [Full Text] [Related]
31. Angel investors shy away from biotech.
Bouchie A
Nat Biotechnol; 2005 Jan; 23(1):145. PubMed ID: 15706637
[No Abstract] [Full Text] [Related]
32. Biotechs hold their own in shifting industry.
Mitchell P
Nat Biotechnol; 2002 Nov; 20(11):1065-6. PubMed ID: 12410238
[No Abstract] [Full Text] [Related]
33. Biotech's wonder ride.
Rynecki D
Fortune; 2000 Mar; 141(5):435-6. PubMed ID: 10788046
[No Abstract] [Full Text] [Related]
34. Bugs or drugs, tortoises or hares?
Jacobs T
Nat Biotechnol; 2005 Mar; 23(3):293. PubMed ID: 15765079
[No Abstract] [Full Text] [Related]
35. Early-stage returns?
Booth BL
Nat Biotechnol; 2006 Nov; 24(11):1335-40. PubMed ID: 17093473
[TBL] [Abstract][Full Text] [Related]
36. Biotech round the world: focus on Canada.
Biotechnol J; 2008 Jul; 3(7):848-51. PubMed ID: 18624341
[No Abstract] [Full Text] [Related]
37. Big pharma wants you.
Mack GS
Nat Biotechnol; 2006 Nov; 24(11):1317-9. PubMed ID: 17162751
[TBL] [Abstract][Full Text] [Related]
38. Biotech at the beauty counter.
Nasto B
Nat Biotechnol; 2007 Jun; 25(6):617-9. PubMed ID: 17557090
[No Abstract] [Full Text] [Related]
39. Any diamonds in the diagnostic coal?
Jacobs T
Nat Biotechnol; 2006 Aug; 24(8):930. PubMed ID: 16900133
[No Abstract] [Full Text] [Related]
40. The stampede to convertibles.
Jacobs T
Nat Biotechnol; 2003 Aug; 21(8):855. PubMed ID: 12894195
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
